SciSparc unit reports quantum-enabled gene-analysis benchmark

SciSparc said its CliniQuantum subsidiary achieved an approximately 16.8-fold computational acceleration in a benchmark using a real clinical gene-expression dataset. The company said the test was for performance only and did not establish clinical validity or utility.